Fairfield, Bush & Co’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-1,819
| Closed | -$194K | – | 151 |
|
2020
Q3 | $194K | Sell |
1,819
-350
| -16% | -$37.3K | 0.06% | 142 |
|
2020
Q2 | $329K | Buy |
2,169
+2
| +0.1% | +$303 | 0.12% | 109 |
|
2020
Q1 | $180K | Buy |
2,167
+350
| +19% | +$29.1K | 0.07% | 123 |
|
2019
Q4 | $307K | Buy |
1,817
+743
| +69% | +$126K | 0.11% | 115 |
|
2019
Q3 | $199K | Buy |
+1,074
| New | +$199K | 0.07% | 143 |
|
2018
Q4 | – | Sell |
-1,029
| Closed | -$236K | – | 148 |
|
2018
Q3 | $236K | Hold |
1,029
| – | – | 0.07% | 146 |
|
2018
Q2 | $229K | Hold |
1,029
| – | – | 0.07% | 149 |
|
2018
Q1 | $235K | Sell |
1,029
-55
| -5% | -$12.6K | 0.07% | 146 |
|
2017
Q4 | $284K | Hold |
1,084
| – | – | 0.08% | 137 |
|
2017
Q3 | $243K | Hold |
1,084
| – | – | 0.08% | 133 |
|
2017
Q2 | $296K | Hold |
1,084
| – | – | 0.09% | 120 |
|
2017
Q1 | $262K | Sell |
1,084
-15
| -1% | -$3.63K | 0.08% | 128 |
|
2016
Q4 | $228K | Sell |
1,099
-200
| -15% | -$41.5K | 0.07% | 132 |
|
2016
Q3 | $354K | Sell |
1,299
-389
| -23% | -$106K | 0.11% | 114 |
|
2016
Q2 | $243K | Sell |
1,688
-200
| -11% | -$28.8K | 0.08% | 121 |
|
2016
Q1 | $271K | Buy |
1,888
+60
| +3% | +$8.61K | 0.1% | 112 |
|
2015
Q4 | $393K | Sell |
1,828
-1,880
| -51% | -$404K | 0.14% | 105 |
|
2015
Q3 | $600K | Buy |
3,708
+96
| +3% | +$15.5K | 0.26% | 67 |
|
2015
Q2 | $932K | Sell |
3,612
-17
| -0.5% | -$4.39K | 0.28% | 74 |
|
2015
Q1 | $817K | Buy |
3,629
+119
| +3% | +$26.8K | 0.24% | 83 |
|
2014
Q4 | $674K | Buy |
3,510
+82
| +2% | +$15.7K | 0.19% | 95 |
|
2014
Q3 | $736K | Buy |
3,428
+665
| +24% | +$143K | 0.21% | 91 |
|
2014
Q2 | $718K | Buy |
+2,763
| New | +$718K | 0.21% | 92 |
|